Compare Gunung Raja Paksi Tbk. (GGRP) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gunung Raja Paksi Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Gunung Raja Paksi Tbk. trades at Rp330 (market cap 4.02T, 1.49M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Gunung Raja Paksi Tbk. is far larger — about 38.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| GGRP | SCPI | |
|---|---|---|
Market Cap | 4.02T | 104.4B |
Volume | 1.49M | — |
Lot | 14.87K | — |
Turnover | 488.12M | — |
Average Price | 328.37 | — |
Value | 488.12M | — |
Indicative Equilibrium Price | 330 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gunung Raja Paksi Tbk.
PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
